Evaluation of interferon alpha-2B and thalidomide in patients with disseminated malignant melanoma, phase 2, SWOG 0026-Reference-Cited by-同舟云学术

Evaluation of interferon alpha-2B and thalidomide in patients with disseminated malignant melanoma, phase 2, SWOG 0026

Published:2007 Issue:10 Volume:110 Page:2269-2275
ISSN:0008-543X
Container-title:Cancer
language:en
Short-container-title:Cancer

Author:

Hutchins Laura F.,Moon James,Clark Joseph I.,Thompson John A.,Lange Marianne K.,Flaherty Lawrence E.,Sondak Vernon K.

Publisher

Wiley

Subject

Cancer Research,Oncology

Reference65 articles.

1. ,,. Malignant melanoma. In: ,, et al., eds. Cancer Medicine. Hamilton, ON: BC Decker. 2003: 1973–2013.

2. Annual Report to the Nation on the Status of Cancer, 1975–2002, Featuring Population-Based Trends in Cancer Treatment

3. Cancer Statistics, 2005

4. ,. Cutaneous melanoma (Chap. 38.2). In: ,, eds. Cancer: Principles & Practice of Oncology.7th ed. Philadelphia: Lippincott, Williams & Wilkins; 2005: 1760–1769.

5. Regional and Systemic Strategies for Metastatic Malignant Melanoma

Cited by 10 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Overcoming Resistance in Relapsed Anaplastic Large-Cell Lymphoma, ALK-Positive (Literature Review and Clinical Experience);Clinical oncohematology;2019

2. Anti-Angiogenesis Therapy for Melanoma;Diagnostic and Prognostic Biomarkers and Therapeutic Targets in Melanoma;2011-11-18

3. High prevalence and risk factors of thromboembolism in stage IV melanoma;Journal of the European Academy of Dermatology and Venereology;2011-02-06

4. Interferon Therapy for Malignant Solid Tumors;Current Drug Therapy;2010-05-01

5. Angiogenesis and Melanoma;Cancers;2010-02-25